Your clinician will weigh risks and benefits and may suggest a different plan if GLP-1s arent a fit
Shauna Levy of the Tulane Weight Loss Center described Zepbound as the most powerful medical obesity treatment available, second only to weight-loss surgery
A newer formulation (Egrifta WR) delivers 1.28mg daily with equivalent efficacy through improved bioavailability
This is especially true for patients with thyroid history, gallbladder disease, pancreatitis risk, diabetes medications, gastrointestinal conditions, eating disorder history, hormone concerns, or significant muscle loss risk
It only takes a few minutes and helps our clinical team understand your goals and health history
Availability and sourcing complexity also differ significantly